Cargando…

Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis

BACKGROUND: Neoadjuvant radiotherapy has been shown to improve marginal negative resection and local control of Pancreatic Ductal Adenocarcinoma (PDAC). However, whether it improves overall survival (OS) in patients with non-metastatic PDAC remains controversial. Therefore, the purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dan, Liu, Chongshun, Zhou, Yuan, Yan, Tingyu, Li, Chenglong, Yang, Qionghui, Xu, Yang, Zhao, Lilan, Pei, Qian, Tan, Fengbo, Güngör, Cenap, Li, Yuqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222314/ https://www.ncbi.nlm.nih.gov/pubmed/32404114 http://dx.doi.org/10.1186/s13014-020-01561-z

Ejemplares similares

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

The Main Bottleneck for Non-Metastatic Pancreatic Adenocarcinoma in Past Decades: A Population-Based Analysis
por: Li, Yuqiang, et al.
Publicado: (2020)

The main contributor to the upswing of survival in locally advanced colorectal cancer: an analysis of the SEER database
por: Li, Yuqiang, et al.
Publicado: (2019)

The Survival Effect of Radiotherapy on Stage IIB/III Pancreatic Cancer Undergone Surgery in Different Age and Tumor Site Groups: A Propensity Scores Matching Analysis Based on SEER Database
por: Wang, Dan, et al.
Publicado: (2022)

The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision
por: Zhou, Yuan, et al.
Publicado: (2022)

A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
por: Li, Yuqiang, et al.
Publicado: (2021)

Predicting pathological complete response by comparing MRI‐based radiomics pre‐ and postneoadjuvant radiotherapy for locally advanced rectal cancer
por: Li, Yuqiang, et al.
Publicado: (2019)

Establishment and Verification of Synchronous Metastatic Nomogram for Gastrointestinal Stromal Tumors (GISTs): A Population-Based Analysis
por: Li, Yuqiang, et al.
Publicado: (2020)

Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study
por: Ge, Heming, et al.
Publicado: (2022)

The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
por: Li, Yuqiang, et al.
Publicado: (2021)

Accurate nomograms with excellent clinical value for locally advanced rectal cancer
por: Li, Yuqiang, et al.
Publicado: (2021)

Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis
por: Zhou, Yuan, et al.
Publicado: (2021)

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis
por: Li, Yuqiang, et al.
Publicado: (2020)

Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score–matching study
por: Zhou, Zhongyi, et al.
Publicado: (2022)

KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomas
por: Wang, Dan, et al.
Publicado: (2023)

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
por: Campos‐Balea, Begoña, et al.
Publicado: (2020)

Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database
por: Zhang, Ning, et al.
Publicado: (2017)

Stage selection for neoadjuvant radiotherapy in non‐cervical esophageal cancer: A propensity score‐matched study based on the SEER database
por: Ma, Ke, et al.
Publicado: (2018)

Development and validation of prognostic nomogram for patients with metastatic gastric adenocarcinoma based on the SEER database
por: Liu, Xianming, et al.
Publicado: (2023)

A nomogram model of postoperative prognosis for metastatic lung adenocarcinoma: A study based on the SEER database
por: Tie, Xiaowei, et al.
Publicado: (2022)

Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer
por: Li, Yuqiang, et al.
Publicado: (2021)

Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database
por: Yang, Jian, et al.
Publicado: (2019)

Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEER Database
por: Wang, Weishen, et al.
Publicado: (2019)

Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis
por: Pausch, Thomas M., et al.
Publicado: (2021)

Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database
por: Huang, Ze-Ning, et al.
Publicado: (2018)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Lei, Lei, et al.
Publicado: (2021)

Nomogram for Predicting Distant Metastasis of Pancreatic Ductal Adenocarcinoma: A SEER-Based Population Study
por: Li, Weibo, et al.
Publicado: (2022)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

Chemotherapy Plus Radiotherapy Versus Radiotherapy in Patients With Small Cell Carcinoma of the Esophagus: A SEER Database Analysis
por: Li, Tao, et al.
Publicado: (2021)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
por: Ng, Sylvia S. W., et al.
Publicado: (2022)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
por: Awad, Seifeldin, et al.
Publicado: (2020)

Is Neoadjuvant Treatment Justified in Clinical T1 Pancreatic Ductal Adenocarcinoma?
por: Kim, Hyung Sun, et al.
Publicado: (2021)

Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma
por: Gartrell, Robyn D., et al.
Publicado: (2022)

Matrix Stiffness and Colorectal Cancer
por: Liu, Chongshun, et al.
Publicado: (2020)

Prognostic value of postoperative radiotherapy in patients with vulvar squamous carcinoma: findings based on the SEER database
por: Li, Miaomiao, et al.
Publicado: (2023)

The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database
por: Luo, Y.
Publicado: (2021)

Predictive Model of Early Death of Resectable Pancreatic Ductal Adenocarcinoma After Curative Resection: A SEER-Based Study
por: Liu, Weikang, et al.
Publicado: (2022)

Bone Metastases Pattern in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Real-World Analysis in the SEER Database
por: Yang, Xiaojing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4925cu9vk0p4frjngtplo01q2l